Impact of clinical trials on Duromine price

duromine-priceClinical studies of drugs for the obesity treatment are the only way, by which pharmaceutical companies can prove the safety and efficacy of a new medicinal product. All clinical trials of obesity drugs are held in compliance with strict international rules. Compliance with these rules guarantees people, that the results of obesity drugs research are authentic and that the rights of patients, participating in the study, will be protected.

Besides, clinical studies of obesity drugs contribute to increasing the availability of new treatment options and innovative drugs for obesity, such as Duromine. Clinical research is a costly and lengthy process. It’s is not surprising that the price of Duromine obesity drug is formed with regard to the cost of clinical trials and constantly held post-marketing studies. The cost of clinical trials for Duromine obesity drug is a commercial secret of iNova Pharmaceuticals Drug Company (Australia), which produces this drug.

Clinical trials on Duromine obesity drug was held in several stages. The researchers can pass to each subsequent phase, only when they get positive results in the previous stages of clinical trials for Duromine obesity drug.

The first experimental use of the drug in humans was conducted on a small group of obese patients. This Duromine obesity drug study involved up to 80 people. Doctors have been examining toxicity, detecting side effects and determining the optimal dosage of the active ingredient, Phentermine, in Duromine obesity drug.

The second phase of clinical trials for Duromine obesity drug involved more than 100 patients. This stage was dedicated to longer and more detailed study of the drug safety profile, depending on Duromine dosage (15mg, 30mg or 40mg of Phentermine). There was also conducted the first comparative study of the drug, by contrast with placebo and standard treatment methods (dieting or exercise).

The third stage was the most time-consuming and expensive part of the clinical trials. This stage of clinical trials for Duromine capsules involved more than a thousand patients. Doctors tested the drug on a large number of people with varying obesity degrees for confirming its effectiveness and identifying rare side effects. Positive completion of this phase allowed iNova Pharmaceuticals Company to submit a request for the drug registration. The TGA approved it.

It is easy to understand, that the cost of clinical trials for Duromine is very high. Clinical studies require expenses for the following:

  • Developing or buying the drug formula
  • Paying salaries to medical personnel
  • Maintaining expensive medical laboratory
  • Having facilities and expensive modern equipment to produce the medicines components
  • Paying bonuses to top managers

Therefore, the policy of many international medical organizations is directed to price control and its reduction for branded weight loss drugs. Manufacturers of branded products (including Duromine) have to bear high costs, pay for development, advertising, work, idea, etc. So, popular weight loss drugs usually have a high price.

Pharmaceutical industry disposes many weight loss drugs that meet the same quality standards, as the brand products. Often, these drugs have the same medical formula and same pharmacological effect in obesity the treatment.

In reality, many generic drugs are produced in the same factories, as the innovative products.